GE Healthcare looks to self-manufacture imaging agent Optison

01/16/2013 | Pharmaceutical Business Review Online

GE Healthcare is seeking approval to independently manufacture Optison, a contrast agent for cardiac imaging. The company has submitted a supplemental new drug application for the agent to U.S. regulators. "While we cannot predict a timeline for regulatory authority approval, we look forward to servicing the U.S. cardiology community directly in 2013," said GE Healthcare's Stephen Lightfoot.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC